Observation study of using a small dose of rituximab treatment for thyroid-associated ophthalmopathy in seven Chinese patients: One pilot study

OBJECTIVE: To report the efficacy, long-term safety, and tolerability of using a small dose (125 mg/m2 weekly for 4 weeks) of rituximab to treat Chinese patients with thyroid-associated ophthalmopathy (TAO). METHODS: Seven patients with active moderate-to-severe TAO were prospectively recruited in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yueyue, Hu, Hao, Chen, Lu, Zhang, Haitao, Yang, Tao, Xu, Xiaoquan, Chen, Huanhuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889535/
https://www.ncbi.nlm.nih.gov/pubmed/36743915
http://dx.doi.org/10.3389/fendo.2022.1079852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889535/
https://www.ncbi.nlm.nih.gov/pubmed/36743915
http://dx.doi.org/10.3389/fendo.2022.1079852

Ejemplares similares